Printed From:

Mucosolvan LA
(Long Acting) 75mg24


Mucosolvan® LA (Long Acting) 75mg capsules is a prolonged-release medication that improves mucus clearance in acute and chronic bronchial and lung disorders with thick mucus.24


Possible side effects
Immune system disorders

Rare: Hypersensitivity reactions
Not known: Allergic reactions including anaphylactic shock, angiooedema (rapidly developing swelling of the skin, subcutaneous tissue, mucosa or tissue under the mucous membrane) and pruritus

Skin and subcutaneous tissue disorders

Rare: Rash, urticaria
Not known: Severe skin reactions (including erythema multiforme, Stevens-Johnson syndrome/toxic epidermal necrolysis and acute generalised exanthematous pustulosis)

Gastrointestinal disorders

Common: Nausea
Uncommon: Vomiting, diarrhoea, digestive disorders, abdominal pain
Very rare: Increased salivation

Respiratory, thoracic and mediastinal disorders

Not known: Dyspnoea (as a symptom of a hypersensitivity reaction)

General disorders and administration site conditions

Uncommon: Fever, mucous membrane reactions

Dosage

For adults and adolescents
aged 12 years and over:

1 capsule once daily

Composition

One prolonged-release hard capsule contains 75 mg ambroxol hydrochloride.

The other ingredients are:
Capsule content: crospovidone, carnauba wax, stearyl alcohol, magnesium stearate
Capsule shell: gelatine, purified water, titanium dioxide (E 171), iron oxide (E 172)

marking: shellac, titanium dioxide (E 171)